Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 29 min ago
Peer-reviewedLicence not statedJournal of hepatology

EASL position paper on preclinical models of steatotic liver disease

  • Suchira Gallage1,2
  • Rui E. Castro3
  • Jennifer Estall4
  • Ira Tabas5
  • Quentin M. Anstee6,7
  • Dina G. Tiniakos6,8
  • Gyongyi Szabo9
  • Jun Yu10
  • Chantal Desdouets11
  • Frank Tacke12
  • Fiona Oakley7,13
  • Mathias Heikenwalder1,2,14,15
15 affiliations
  1. 1University of Tübingen, Faculty of Medicine, Institute for Interdisciplinary Research on Cancer Metabolism and Chronic Inflammation, M3 Research Center for Malignome, Metabolome and Microbiome, Otfried-Müller-Straße 37, 72076 Tübingen, Germany
  2. 2German Cancer Research Center (DKFZ), Division of Chronic Inflammation and Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
  3. 3Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal
  4. 4Institut de recherches cliniques de Montréal (IRCM), Cardiometabolic Health Centre, Montreal, QC, Canada
  5. 5Department of Medicine and Digestive and Liver Disease Research Center, Columbia University Irving Medical Center, New York, NY 10032, USA
  6. 6Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
  7. 7Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  8. 8Department of Pathology, Aretaieion Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece
  9. 9Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
  10. 10Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China
  11. 11Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, Paris, France, Genomic Instability, Metabolism, Immunity and Liver Tumorigenesis Laboratory, Equipe Labellisée LIGUE 2023, Paris, France
  12. 12Department of Hepatology & Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany
  13. 13Newcastle Fibrosis Research Group, Bioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
  14. 14Cluster of Excellence iFIT (EXC 2180) “Image-Guided and Functionally Instructed Tumour Therapies ”, Eberhard-Karls University of Tübingen, Tübingen, Germany
  15. 15Cluster of Excellence CMFI (EXC 2124) “Controlling Microbes to Fight Infections”, University of Tübingen, Tübingen, Germany
Read full textPDFDOICite

Related

  1. European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease
    Jake Peter Mann, Sander Lefere, Maarten Buytaert +28
    Journal of Pediatric Gastroenterology and NutritionPeer-reviewedCC BY8 citedEpidemiology & public healthOpenAlex
  2. The liver–muscle axis in metabolic dysfunction-associated steatotic liver disease: a narrative review and conceptual framework for body-composition phenotyping
    Zhendong Ma, Xinri Zhang, Yan Leng +1
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
    Zhenghong Xie, Tianxing Chen
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. A rare diagnosis during evaluation for metabolic dysfunction associated steatotic liver disease: Glycogen storage disease type Ia presenting during adolescence in a male with severe obesity
    Carolena Trocchia, Rachel Herdes, Jodi Gedallovich +1
    JPGN reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
    Brandon J. Perumpail, Andrea Tou, Jennifer Panganiban
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{gallage2026easl,
  title = {{EASL position paper on preclinical models of steatotic liver disease}},
  author = {Suchira Gallage and Rui E. Castro and Jennifer Estall and Ira Tabas and Quentin M. Anstee and Dina G. Tiniakos and Gyongyi Szabo and Jun Yu and Chantal Desdouets and Frank Tacke and Fiona Oakley and Mathias Heikenwalder},
  journal = {Journal of hepatology},
  year = {2026},
  month = may,
  doi = {10.1016/j.jhep.2026.04.029},
  url = {https://doi.org/10.1016/j.jhep.2026.04.029},
}
RIS
TY  - JOUR
TI  - EASL position paper on preclinical models of steatotic liver disease
AU  - Suchira Gallage
AU  - Rui E. Castro
AU  - Jennifer Estall
AU  - Ira Tabas
AU  - Quentin M. Anstee
AU  - Dina G. Tiniakos
AU  - Gyongyi Szabo
AU  - Jun Yu
AU  - Chantal Desdouets
AU  - Frank Tacke
AU  - Fiona Oakley
AU  - Mathias Heikenwalder
PY  - 2026
DA  - 2026/05/27
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2026.04.029
UR  - https://doi.org/10.1016/j.jhep.2026.04.029
SN  - 0168-8278
SN  - 1600-0641
ER  -